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A Turning Point Review
in Schizophrenia Genetics
genetic background acting early in life, possibly in con-
cert with events of environmental origin. Most of the
evidence for a genetic component in schizophrenia
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²Center for Neurobiology and Behavior comes from family, twin, and adoption studies (Kallman,
1938, 1946; Heston, 1966; Kety et al., 1978; GottesmanCollege of Physicians and Surgeons
Columbia University and Shields, 1982; Farmer et al., 1987; Onstad et al.,
1991; Kendler et al., 1993a; Kety et al., 1994). ResultsNew York, New York 10032
from these studies can be summarized as follows. First,
family studies demonstrated that an individual's lifetimeIntroduction
risk of developing schizophrenia increases exponen-
tially with degree of relation to an affected individual.
Schizophrenia has been called ªarguably the worst dis-
For example, compared with the z1% risk the general
ease affecting mankind.º The worldwide lifetime preva-
population has to develop schizophrenia, the risk to
lence of the disorder is z1%. In 1990, the cost of caring
first cousins of schizophrenics is z2%, the risk to their
for patients with schizophrenia in the United States was
siblings is z9%, and the risk to someone with both an
estimated to be $33 billion, accounting for z2.5% of
affected sibling and a parent is z16%. Second, twin
total health care expenditures. The substantial funds
studies comparing the concordance for schizophrenia
being spent on the disease only reach a fraction of the
in monozygotic (MZ) twin pairs (who, in principle, share
affected population, since an estimated third to half of
all of their genes) with the concordance in dizygotic (DZ)
the homeless population, who never receive care, suffer
twin pairs (who share half of their genes) demonstrated
from schizophrenia.
that theMZ concordance rate (46%±48%) is significantly
In the absence of good biological markers, schizo-
higher than the DZ rate (4%±14%). Gottesman and
phrenia is defined in terms of a clinical syndrome. Case
Shields (1982) found a slightly higher (58%) concor-
identification usually begins with the observation of psy-
dance rate in a small number of MZ twin pairs who had
chotic symptoms (delusions, hallucinations) and bizarre
been brought up apart. Third, adoption studies compar-
behavior, but many patients also have ªnegativeº symp-
ing the prevalence of schizophrenia in biological rela-
toms, including low levels of emotional arousal, mental
tives who have been separated by adoption early in life
activity, and social drive. Long-standing impairment is
and in adoptive, not genetically related relatives who
observed in patients with schizophrenia. A number of
shared the same environment demonstrated that preva-
relatively precise operational definitions of the syn-
lence of schizophrenia is higher in the biological than
drome exist, such as those in the editions of the Diag-
in the adoptive relatives.
nostic and Statistical Manual of Mental Disorders (DSM;
Taken together, these observations suggest the pres-
American Psychiatric Association, 1987), which when
ence of a strong genetic component in the susceptibility
used in conjunction with standardized research inter-
to schizophrenia. At the other end, probable environ-
views can lead to a reliable, valid, and ªheritableº diag-
mental insults may include obstetric complications or
nosis of the disease.
birth traumas (McNeil, 1995), extreme nutritional defi-
There is a mounting body of evidence from a series
ciency of the mother during early gestation (Susser et
of neuropathological and magnetic resonance imaging
al., 1996), viral infections and autoimmune disorders
(MRI) studies to support the view that schizophrenia can
(Wright and Murray, 1996), and other unspecified envi-
be a consequence of disturbances in development of
ronmental factors.the brain starting probably as early as during the intra-
uterine life (Weinberger, 1987; Murray and Lewis, 1987;
Definition of the Genetic ContributionMurray, 1994; Cannon and Marco, 1994). Volume or neu-
A disease that can be attributed entirely to the effectron loss (not associated with signs of degenerative or
of a single mutated gene is referred to as Mendelian.inflammatory processes) as well as disordered arrange-
Mendelian diseases follow very specific patterns of in-ments of neurons have been observed in several brain
heritance in families (recessive, dominant, or X-linked).structures (Akbarian et al., 1993a, 1993b). The basis
In some cases, what appears to be a single Mendelianof these disturbances is unknown, but it may involve
disease entity may, in fact, be a cluster of differentabnormalities of cell migration, cell death, failure of neu-
mutations. This phenomenon is referred to as geneticrons to make proper connections, and so on. As the
heterogeneity and can be caused by mutations oc-affected structures represent critical ªnodal stationsº
curring independently at the same genetic locus (allelicin the circuits connecting the association cortex with
heterogeneity) or at different genetic loci (nonallelic het-subcortical structures, the aberrant organization of neu-
erogeneity). Heterogeneity can be detected when differ-rons is likely to have major consequences for higher
ent mutations are associated with distinct clinical char-cortical function.
acteristics of a given clinical syndrome or when differentThis aberrant development of cerebral structure and
inheritance patterns of a syndrome are observed in dif-function seems to be a consequence of a susceptible
ferent families. It should be noted that the concept of
genetic heterogeneity, strictly speaking, applies to Men-
delian diseases. Often (including in the present paper),³To whom correspondence should be addressed.
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this term is used to describe the genetic complexity of alleles, although they are necessary to confer increased
risk, are not sufficient to cause the disease. It should beschizophrenia, albeit in a different context. Mendelian
models (simple or heterogeneous) can be discounted in noted, however, that a mode of transmission consistent
with multiple, common, interacting, and weakly pene-schizophrenia heritability on several grounds, including
the evidence that over half of MZ twins remain well when trant mutations does not necessarily preclude the possi-
bility of a single locus with a very large effect (a Mende-their twin becomes ill. In addition, in schizophrenia, the
ratio of risk to first-degree relatives compared to popula- lian-type gene) operating in a rare subset of cases.
Usually, one line of evidence pointing toward such ation frequency (in the range of only 2- to 10-fold) is far
below Mendelian ratios (which are orders of magnitude gene is a clinical criterion such as age at onset, with
early onset disease presenting Mendelian transmission.higher, due to the highly familial nature). Finally, the high
prevalence of schizophrenia, which is also the case for A relevant example is Alzheimer's disease, which is very
common in late adulthood (eighties and nineties) butmost major psychiatric disorders, sharply contrasts with
typical Mendelian disorders, which tend to be very rare. very rare in early adulthood (forties and fifties). Identifi-
cation of multigenerational pedigrees with many casesIn the latter case, mutant alleles with deleterious ef-
fects on reproduction are eliminated from a population of early onset Alzheimer's disease and inheritance con-
sistent with a Mendelian autosomal dominant mode ledthrough natural selection, which is especially effective
for dominant alleles (for example, the most common to gene identification and facilitated progress in under-
standing disease mechanisms immensely (Levy-Lahaddominant diseases tend to have a population frequency
on the order of 1 in 10,000). However, if the effect of the et al., 1995; Sherrington et al., 1995). Unfortunately, in
the case of schizophrenia, it has been difficult to identifydisease allele on reproductive capacity was the only
factor controlling disease frequency, it would be ex- a Mendelian-type subset of cases using clinical charac-
teristics.pected that a disease such as schizophrenia, with a
relatively early age of onset and a demonstrated effect Finally, it should be noted that schizophrenia shows
familial coaggregation with a collection of personalityon reproduction, would be much less prevalent. As it
happens, prevalence of a disease is also affected by its traits known as schizotypy or schizotypal personality
disorder, as well as with schizoaffective disorder, atypi-mode of inheritance, as is nicely demonstrated in the
case of maturity onset-type diabetes of youth (MODY) cal psychotic disorders, and avoidant and paranoid per-
sonality disorders. Some of these disorders occur in theand insulin-dependent diabetes mellitus (IDDM). Both
diseases have a roughly comparable age of onset. Of relatives of probands with schizophrenia more com-
monly than schizophrenia itself (Kendler et al., 1993b).the two, MODY is the far more clinically benign and
compatible with survival and reproduction, as it often Moreover, in some families, there is coaggregation of
both schizophrenia and bipolar disorder, suggesting thegoes undiagnosed for decades without requiring insulin
therapy. In contrast, IDDM is far more clinically severe, possibility of some shared vulnerability (Cloninger, 1994;
Crow, 1994).requiring insulin for survival (before the introduction of
insulin, patients were likely to die from their disease).
Paradoxically, it is the severe form, IDDM, that is far Molecular Genetic Strategies and Recent Progress
more common than the benign form, MODY. The reason Family, twin, and adoption studies provide overwhelm-
for this, in part, is that the genetic inheritance pattern ing but indirect evidence for a significant genetic contri-
of IDDM is complex, whereas the inheritance pattern of bution to the etiology of schizophrenia. More recent
MODY is Mendelian and thus quite rare, even when the studies using genetic markers provide a more direct
effects are relatively benign. approach to the identification and localization of genes.
The critical question then becomes: what is the ge- Current investigative efforts present a remarkable diver-
netic basis of complex inheritance in schizophrenia that sity and include any of the strategies outlined below.
allows disease alleles toescape natural selection? Obvi-
ously, an answer to this question is important for design-
Linkage Analysising and interpreting studies tomap genes for such disor-
In the past 15 years, linkage studies using DNA markersders. As noted above, the mode of inheritance of the
in multigenerational pedigrees with multiple affected in-disease is not simple (Risch and Baron, 1984; Kendler
dividuals had a great impact on diseases for which theand Diehl, 1993) and involves, in all likelihood, both
etiological basis is unknown or poorly understood. Link-genes and environmental influences (Gottesman and
age studies in complex disorders are based on threeShields, 1982). Theoretical analyses as well as data from
assumptions: (1) that despite the inherent complexitiesrecent molecular genetic studies suggest that high ge-
in the transmission of a disease, etiological heterogene-netic ªheterogeneityº exists in schizophrenia (Risch,
ity exists; (2) that a gene of major effect segregates in1994; Tsuang and Faraone, 1995), which, unlike Mende-
at least a proportion of the families, and within-familylian-type heterogeneity, has the form of overlapping sets
homogeneity exists; and (3) that the mode of inheritanceof interacting genes predisposing individuals to the
can at least be approximately inferred. Two loci (e.g., asame disease. Moreover, unlike Mendelian disorders
DNA marker locus and a disease locus) are said to becaused by highly penetrant but rare functional polymor-
genetically linked when the probability of a recombina-phisms (mutations) in a single gene, schizophrenia (and
tion event (called the recombination fraction) occuringcomplex psychiatric disorders in general) are likely to be
between these two loci is below 50% (which equalsassociated with low penetrance but common functional
the probability of recombination of two unlinked locivariations in the involved susceptibility genes (alleles
of weak or moderate effect). Individual susceptibility residing on two different chromosomes). Indeed, the
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object of classical genetic linkage analysis is to estimate informative. A disadvantage of the nonparametric meth-
ods is that the power of the method is low (large samplethe recombination fraction and to test whether an ob-
served deviation from 50% recombination is statistically sizes are required, as many as several thousand sib-
pairs for genes of weak effect [Risch and Merikangas,significant. Because in most human pedigree data it is
impossible to count recombinants and nonrecombi- 1996]), and therefore it is more appropriately employed
in the detection of genes of major or moderate effect.nants, researchers usually use likelihood-based meth-
ods and sophisticated analysis programs to evaluate Even in this case, several hundred sib-pairs are neces-
sary. It is likely that the requirement for large samplethe likelihood of a given pedigree under different as-
sumptions about the recombination fraction between sizes can be relaxed if the target population presents
lower genetic complexity at the susceptibility loci, astwo loci (Ott, 1991). The test statistic used for this pur-
pose is called lod score, and by convention a critical may be the case for populations founded by a small
number of individuals or populations who experiencedvalue of 3 is accepted as significant evidence for linkage
in simple Mendelian disorders (in such disorders, a lod in the past a significant ªbottleneck,º when the number
of surviving and reproducing individuals might havescore of 3 signifies that about 5% of such findings can
be expected to be actually spurious). been dramatically reduced.
In interpreting linkage results in schizophrenia, it isThis strategy has been successfully employed in dis-
eases where Mendelian subgroups could be identified, important to keep in mind that the lod score statistic of
3 for significance, usually employed in linkage studies,but unfortunately it is clear now that noneof theassump-
tions outlined above are likely to be satisfied in schizo- was defined for Mendelian diseases, for which there is
strong a priori belief in the existence of a single geneticphrenia inheritance. Moreover, it has become apparent
in the last few years that in the presence of polygenic locus. When the disease being mapped is non-Mende-
lian and there is no information on whether a locus ofor oligogenic inheritance, the choice of large pedigrees
can pose serious disadvantages. For example, large, sufficient effect actually exists, the false-positive rate
may actually be higher. For that reason, stricter statisti-densely affected pedigrees are actually more likely to
have multiple disease genes segregating than are cal criteria have been proposed for complex psychiatric
disorders (Lander and Kruglyak, 1995), which, however,smaller, less densely affected ones (Durner et al., 1992),
thus complicating the analysis. Moreover, parents of might be unrealistic given the mode of inheritance of the
disease and the size of the family collections currentlymultiple affected children have an increased probability
of being homozygous at the disease locus and not infor- available for genetic studies. An alternative set of criteria
that seems to inspire confidence within the field is amative for linkage (Risch, 1994). In addition, large family
linkage studies traditionally use the lod score method of positive lod score finding (preferably of a value higher
than 1 or 2) along with independent replications of theanalysis, which requires specification of certain genetic
parameters such as mode of inheritance, gene frequen- original finding. The importance of a replicated finding
in complex psychiatric disorders is underscored by thecies, and penetrance (parametric linkage analysis; Ott,
1991). Because the exact mode of inheritance is un- fact that the waiting time (defined as the number of
families needed to be tested) to make an initial linkageknown, analyses are usually undertaken using a number
of genetic models. This increases the risk for inflating detection is shorter compared to the waiting time re-
quired to replicate a previous linkage detection (SuarezType 1 errors (false positives) due to multiple testings.
Type 2 errors (false negatives) may also occur if the et al., 1994). The reason is that in the former case, many
markers are assayed simultaneously (due to the hightrue mode of inheritance is not included in the analysis
(Lander and Schork, 1994). Lastly, linkageresults in large genetic heterogeneity) and, in principle, compete with
one another, whereas in the latter case only one markerfamilies can be sensitive to genotyping errors or changes
in diagnosis of single individuals (Kelsoe et al., 1989). is being assayed (the one marker previously implicated).
Over the past few years, highly polymorphic markersTwo complementary strategies have been employed
and optimized to allow the identification of susceptibility more or less evenly spaced throughout the genome have
become increasingly available, and these have madegenes. The first is a nonparametric linkage analysis
based on allele sharing in pairs of affected relatives. The feasible a genome-wide search for schizophrenia sus-
ceptibility loci. Results from several genome wide scanssecond (described in the next section) is association
studies on samples of unrelated individuals. In nonpara- are now available (Barr et al., 1994; Coon et al., 1994a,
1994b; Karayiorgou et al., 1994; Pulver et al., 1994a;metric linkage approaches (Shah and Green, 1994), evi-
dence for linkage is inferred if affected pairs share more Moises et al., 1995a). Based on empirical data from
these studies, it is now clear that by using linkage strate-alleles at a given marker locus than would be expected
by chance. The simplest version is the affected sibling gies to identify schizophrenia susceptibility genes, one
can define regions of interest, albeit relatively broadly,pair method that has already been used successfully in
other complex disorders, such as type 1 diabetes melli- most likely due to limitations posed by the high degree of
heterogeneity and the moderate effects of the involvedtus (Davies et al., 1994). Investigations of sib-pairs have
several advantages over the multiplex families ap- genes. Despite the effort involved, none of the reported
genome scans had enough families to overcome theseproach: (1) pairs of affected siblings are less atypical
than multiplex families and more readily available in limitations and establish conclusive evidence for linkage
that would permit immediate pursuit of gene identifica-large numbers, (2) the mode of inheritance need not
be specified, (3) linkage results are less sensitive to tion through cloning strategies. Nevertheless, cumula-
tive evidence from replication efforts (including interna-laboratory or clinical errors, and (4) parents are more
likely to be heterozygous at the disease locus and thus tional multi-center ones) is now available to suggest
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with reasonable confidence (enough to justify further recessive model for locus D8S261, the most telomeric
of the five markers tested. Affected sib-pair analysisgenetic and biological studies) that schizophrenia sus-
indicated significant allele sharing for marker D8S133.ceptibility genes may be found in relatively broad re-
In biological terms, a potentially interesting observa-gions on chromosome 22q, chromosome 8p, and chro-
tion is that the 8p region implicated in these studiesmosome 6p. In the summaries of the findings implicating
overlaps with the shortest region of overlap (SRO) for athese regions, provided below, the following points need
form of agenesis of corpus callosum (ACC). Indeed, oneto be emphasized. First, depending on the structure of
of the most consistent chromosomal rearrangementsthe affected pedigrees, a given data set is analyzed
associated with ACC is dup8(p21p23) (Dobyns, 1996),usually with both classical parametric and nonparamet-
suggesting that this region might harbor genes influenc-ric affected sib-pair methodologies. In the most convinc-
ing neuronal connectivity. Interestingly, a systematicing studies, results from both of these analyses are in
MRI study (Swayze et al., 1990) reported partial ACC inagreement. Second, due to the nature of the genetic
z2% of schizophrenia patients (versus 0.005%±0.07 incomponent of the disease, collaborative international
the general population), indicating an abnormal devel-and multi-center efforts are usually undertaken to pro-
opment of CC and/or of the developmentally relatedvide independent support to the strongest and most
limbic structures in schizophrenia.consistent findings of individual research groups.
Chromosome 6pChromosome 22q
The short arm of chromosome 6 and, more specifically,This region was first identified in the Johns Hopkins
the resident human leukocyte antigen (HLA) locus haveUniversity/Massachusetts Institute of Technology (JHU/
been the object of intense study in the ªpremolecularMIT) genome scan (Pulver et al., 1994a) and represents
eraº of psychiatric genetics. More recently, a study ofthe first finding of sustained research interest in the
186 Irish families (Wang et al., 1995) reported linkage atfield. Initially, using parametric linkage analysis, a maxi-
the distal end of this arm. Straub et al. (1995) analyzedmum lod score of 2.85 was obtained from 39 multiply
the entire cohort of 265 (including the 186) Irish familiesaffected families under a dominant model for the marker
and reported evidence for linkage in z15%±30% of themIL2RB in 22ql3. At about the same time, Coon et al.
in the 6p24-22 region. A maximum lod score of 3.5 was(1994a, 1994b) reported a lod score of 2.09 toward the
reported for marker D6S296, and there was also sugges-distal end of the chromosome for marker D22S276 under
tive but weaker evidence for allele sharing of the same
a recessive model, as part of their genome search using
marker among sib-pairs. Several groups followed up
a sample of nine multiply affected families. Application
this suggestion of linkage by typing markers in bothof this model to the JHU/MIT extended sample of 57
6p24-22 and in the more centromerically located HLA
families gave the highest overall lod score (1.20) for
region (6p21). Several samples, including the large col-
locus CRYB2 at 22q11 (Lasseter et al., 1995). Thus, no
laborative effort described above (Schizophrenia Col-
region of 22q could be excluded, and the most likely
laborative Linkage Group for chromosomes 3, 6, and
region included q11-q12. Since then, additional groups 8, 1996), provided positive evidence spreading over a
genotyped markers in the region. Most of these studies region of 40 cM, supporting the existence of a schizo-
genotyped and provided positive results for the marker phrenia susceptibility locus on 6p.
D22S278 in 22q12 (Vallada et al., 1995; Moises et al., Other regions
1995b). A multi-center collaborative effort (Schizophre- Other emerging promising regions include chromo-
nia Collaborative Linkage Group for chromosome 22, somes 13q14.1-q32, 5q21-q31, and 18p. The locus at
1996) analyzed genotypings of this marker provided by 13q is particularly intriguing, as it harbors the gene for
11 independent research groups worldwide, by employ- the 5-HT2A receptor, recently implicated in schizophre-
ing an affected sib-pair analysis on a sample of 296 nia by association studies (see below). Independent evi-
affected sib-pairs, and revealed significant allele sharing dence suggesting the existence of a susceptibility gene
by affected individuals for this marker. At present, the for schizophrenia in region 13q14.1-q32 had initially
region of interest on chromosome 22 includes the entire been reported in a linkage study of 13 schizophrenia
long arm, and it might contain more than one distinct pedigrees (Lin et al., 1995). A more recent study (Anto-
loci (see also below). narakis et al., 1996) provided further support for this
Chromosome 8p22-p21 region. The relation, if any, between the association and
This region was also first identified in the JHU/MIT the linkage results still remains unclear.
(Pulver et al., 1995) genome scan. In the initial report of Suggestive evidence for linkage at the 5q21-31 locus
linkage in this region, the maximum lod score was 2.35 was provided independently by two groups (Straub et
under the dominant model for the marker D8S136 and al., 1997; Schwab et al., 1997). It should be noted that
2.20 for the same marker under the recessive model. In this chromosomal region is different than the area 5q11-
addition, analysis of allele sharing among affected sib- q13 initially implicated in schizophrenia in 1988 (see
pairs provided themost significant evidence for a nearby below; Bassett et al., 1988; Sherrington et al., 1988). It
marker (D8S258). Further support for the presence of a is of interest to note that this region contains several
susceptibility locus in this region was provided by more candidate genes encoding immunological molecules
recent follow-up studies. The most important of these (such as Interleukin-13, 24, 25, 23, and 29; Marquet
studies genotyped 567 informative pedigrees from 14 et al., 1996). Very recently, our group provided further
independent research groups for five markers on 8p evidence in support of a susceptibility locus at this re-
(D8S261, D8S258, D8S133, D8S136, and D8S283; Schizo- gion by identifying a 5q21-23.1 interstitial deletion en-
phrenia Collaborative Linkage Group for chromosomes compassing the linked markers in a patient with schizo-
3, 6, and 8, 1996). The maximum lod score was 2.22 phrenia and dysmorphic features (Bennett et al., 1997;
see also below).for 13 groups (independent replication sample) under a
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The locus at 18p (Wildenauer et al., 1996) is also in- et al., 1996, 1997a). It is likely that this kind of analysis
will provide objective criteria to define an etiologicaltriguing because the same region has been implicated
previously insusceptibility to affective disorders (Berret- stratification of schizophrenia.
Association studies have several practical advan-tini et al., 1994). A lod score of 2.2 has been reported
for the marker D18S53 at this locus, for schizophrenia tages over linkage studies, namely that (1) families with
multiple affected individuals, which are relatively scarce,only, in a sample of 85 sib-pairs. Interestingly, the lod
score increased to 2.6 when individuals with affective are not required; (2) no assumptions are made about
the mode of inheritance of the disease; and (3) they havedisorders (bipolar, major depression) were included in
the analyses. considerable statistical power to detect genes of weak
effect, unlike linkage studies in families. For example, ifFurther studies (including international multi-center
collaborative ones) are needed to verify these results, an allele that occurs naturally in 10% of the population
doubles an individual's risk to disease, then one wouldestimate the contribution of these potential loci to the
phenotype of schizophrenia, and help narrow down the need more than 5000 affected sib-pairs todetect linkage
at lod . 3. If, however, an association study design wascandidate genomic regions.
followed instead, one could detect the same effect with
a sample of around 700 family trios (Risch and Merikan-
Association Studies gas, 1996). This large discrepancy in power may be
Association studies are based on the assumption out- responsible for some of the negative linkage results in
lined above, that complex psychiatric disorders are regions where allelic associations have been detected
likely to beassociated with low penetrance but common, (Collier and Sham, 1997). The limitation of association
functional variations in a number of susceptibility genes. studies is that candidate genes, as well as functional
Instead of probing vertically for an association between polymorphisms within these genes or at least polymor-
a disease and a marker in a few extended pedigrees, phisms in strong disequilibrium, must be identified first
these studies analyze potential associations in a sample before the test can be performed. The reason is that in
of unrelated subjects and healthy controls or in a sample heterogeneous populations, departure from the ex-
of unrelated family trios (unrelated affected subjects and pected distribution is only detectable very close to or
both their parents). Two experimental designs are used at the ªassociatedº polymorphism. This requirement is
more frequently. In one design (case/control studies), daunting and has so far restricted this approach to (1)
the distribution of a specific allele of a polymorphic locus testing the few known candidate genes and (2) nar-
is tested in affected individuals compared to controls rowing down the regions of interest after preliminary
who have been matched by ethnicity, sex, and age and identification by linkage studies in multiplex pedigrees
have preferably been psychiatrically evaluated. Prob- (this analysis uses samples of family trios independent
lems with this design include stratification effects, where of the sample used to establish linkage and depends
a section of the population contains a disease and a heavily upon access to the data assembled in the con-
marker allele more commonly than expected without a text of the Human Genome Project).
causal relationship between them (population stratifica- As it is likely that only a portion of the loci harboring
tion might be less concerning if association is identified schizophrenia susceptibility genes will be identified by
in distinct subsets of patients). Another design, the linkage studies, it has been suggested (Risch and Meri-
Transmission Disequilibrium Test (TDT; Terwilliger and kangas, 1996) that the limitations to detecting many of
Ott, 1992; Spielman et al., 1993), tests the transmission the remaining genes could be overcome by genomic
of a particular allele from a parent to the affected individ- association studies that are more suitable for detecting
ual using the other untransmitted allele from the parent genes of weak effect. In a genomic association scheme,
as the ªcontrol.º As both the experimental and the con- a large number of genes and polymorphisms (preferen-
trol alleles are drawn from the same gene pool, this test tially ones that create alterations in derived proteins or
mitigates the need for well-matched controls. In both their expression) must first be identified (partly as a
methodologies, differences in the distribution or trans- byproduct of the Human Genome Project), and an ex-
mission of alleles may suggest that the marker itself tremely large number of biallelic polymorphisms will
may have some direct influence on susceptibility to the need to be tested on several hundred families. It has
disease or, alternatively, that the marker allele may be been estimated that systematic mapping by association
very closely linked to the disease allele (it is in linkage requires a marker map of density at least 100-fold
disequilibrium). Often, this analysis treats patients with greater than that for linkage mapping. Risch and Meri-
schizophrenia as a single entity. Paradoxically, if the kangas (1996) analyzed this requirement in some detail
gene under test contributes to the manifestation of and concluded that these limitations are imposed by
schizophrenia only in a subset of patients, or modifies current technological capabilities and not by an insuffi-
the clinical manifestation of the disease, the frequency cient number of families with the disease or inadequate
of the disease allele in the individuals with schizophrenia statistical power. For that reason, more efficient meth-
(when grouped as a single entity) will be very similar to ods of screening large numbers of polymorphisms such
the control frequency. For that reason, when a sufficient as sample pooling, high density DNA arrays (Chee and
number of patients are available, the distribution of ge- Fodor, 1996) must be optimized and applied. It is likely
notypes among the schizophrenia subjects is also ex- that the required number of markers and familiesneeded
amined in relation to several variables such as gender, for initial screening could be reduced if one allows for
family history, presence of comorbid conditions, re- linkage disequilibrium or if the screening is performed
sponse to treatment, and so on (Jonsson et al., 1993; in a more homogeneous population (genetic isolates).
As mentioned above, association studies are moreNimgaonkar et al., 1993a; Mant et al., 1994; Karayiorgou
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meaningful when applied to functionally significant vari- is eventually confirmed in larger samples, it will be most
certainly associated with significant heterogeneity andations within the coding region, 59 and 39 untranslated,
as well as the control elements of clear candidate genes. a small increase in relative risk (most likely ,2-fold).
More recently, Williams et al. (1997) have performed TDTAs more genes of interest are sequenced, this approach
is becoming increasingly feasible, although for now analysis to family data from nine European centers and
provided additional evidence to support the associationthere are few clear pathophysiological hypotheses upon
which this approach can be based. Nevertheless, the between highly familial schizophrenia and excess homo-
zygosity at the Bal1 D3 locus.list of the genes tested so far is quite extensive to be
described within the confines of the present paper. The Because of their putative role as principal sites of
therapeutic action of atypical neuroleptics, recent atten-majority of these studies reported negative results, but
in many cases the power of the samples used was not tion has also focused on the possible involvement of
5-hydroxytryptamine type 2A (5-HT2A) receptors in schizo-enough to detect genes of modest or weak effect. Some
investigations have provided promising preliminary evi- phrenia. Williams et al. (1996), testing a large case/con-
trol European sample, have provided evidence support-dence of an association between susceptibility to schizo-
phrenia and genes fitting several candidate models, in- ing an association between schizophrenia and the
T102C polymorphism of the gene for the 5-HT2A recep-cluding models of dopaminergic dysfunction (Crocq et
al., 1992; Mant et al., 1994; Wei et al., 1995; Karayiorgou tor previously described in a smaller sample (Arranz
et al., 1995; Inayama et al., 1996). A significant overallet al., 1996, 1997a; Li et al., 1996; Shaikh et al., 1996),
models of serotonergic dysfunction (Arranz et al., 1995; association between schizophrenia and allele 2 and a
significant excess of the 1±2/2±2 genotypes in schizo-Inayama et al., 1996; Williams et al., 1997), viral/auto-
immune theories (Nimgaonkar et al., 1993b,1995; Wright phrenia were reported (relative risk of z1.7). The T102C
polymorphism does not change the amino acid se-et al., 1996), and neurodevelopmental disturbances (Nanko
et al., 1994; Dawson et al., 1995). Although still contro- quence of the protein, although it is possible that it could
affect the secondary structure and stability of the mRNAversial, results from the two studies described below
represent the most convincing large scale attempts to (Arranz et al., 1995). Erdmann et al. (1996) have carried
out a mutation analysis of the whole coding region andidentify schizoprenia susceptibility genes using associa-
tion studies. In addition, they provide useful information have reported two coding polymorphisms, neither of
which appears to show an allelic association withon technical and interpretation problems associated
with the identification of weak-effect genes in psychiat- schizophrenia. The possibility of pathogenetic variants
in the promoter or other regulatory regions has not yetric disorders.
Disturbances of dopaminergic neurotransmission have been addressed.
Despite the fact that both D3 and 5-HT2AR geneslong been implicated in the pathogenesis of schizophre-
nia. Five types of Gprotein-coupled dopamine receptors seem to have at best a weak effect on schizophrenia
susceptibility, these could in principle be important find-have been characterized; D1 and D5 (D1 family) stimu-
late adenylate cyclase, whereas D2, D3, and D4 (D2 ings, as they could offer an anchor for further biological
studies. Unfortunately, in both cases the possibility offamily) inhibit adenylate cyclase. Receptor families differ
in their pharmacological specificity, with typical antipsy- true causative relationship could not be demonstrated
(e.g., by functional assays of the variant), and the possi-chotic drugs having a high affinity for D2-like receptors.
Accordingly, much recent attention has focused on the bility of linkage disequilibrium with a nearby locus still
remains open.members of the D2 family and in particular D3, which
is largely confined to limbic areas of the brain (implicated
in the pathogenesis of schizophrenia); it is inhibited by
Search for Chromosomal Abnormalitiesand its expression is up-regulated by administration of
Identification of chromosomal changes, including trans-both typical (e.g., haloperidol) and atypical (e.g., cloza-
locations and deletions in affected individuals, havepine) neuroleptics (Buckland et al., 1992). The human
been invaluable for identifying disease genes (such asD3 receptor maps to chromosome 3q13.3 and presents
genes involved in leukemias and other forms of humana polymorphic site in the first exon that gives rise to
cancer; Rabbitts, 1994; Nowell, 1997). Chromosomala glycine-to-serine substitution in the amino-terminal
changes have also been described in association withextracellular domain (and produces a Bal1 restriction
mental disorders, especially schizophrenia (reviewed bysite; Lannfelt et al., 1992). The functional significance of
Bassett, 1992). Indeed, one of the very first molecularthis change is still unknown. However, an association
studies on schizophrenia, done in the era before thebetween schizophrenia and increased homozygosity at
advent of the Human Genome Project, was based onthe Bal1 D3 receptor polymorphism has been observed
the work of Bassett et al. (1988), who reported an Asian(Crocq et al.,1992, 1995; Nimgaonkar et al., 1993a;Owen
family in which the two family members with schizophre-et al., 1993; Mant et al., 1994), although contradictory
nia were found to have a partial trisomy of the chromo-results have also been reported (Nanko et al., 1993a;
somal segment 5q11.2-13.3 caused by an unbalancedNothen et al., 1993; Yang et al., 1993; Sabate et al.,
translocation of the long (q) arm of chromosome 5. This1994). Some of the positive studies found increased
led to speculation that this region of chromosome 5levels of homozygosity in schizophrenics who were
carries a susceptibility gene for schizophrenia, andgood responders to neuroleptics (Jonsson et al., 1993)
Sherrington et al. (1988) provided initial results thator in schizophrenics with a family history of the disease
seemed to indicate the presence of a dominant gene in(Nimgaonkar et al., 1993). Obviously, the jury is still out
for D3, and if the homozygosity effect in schizophrenia the vicinity of the chromosomal anomaly. Unfortunately,
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other research teams were unable to confirm this find- microdeletion in the general population is estimated to
be 2 in 10,000, and no deletions were found in a sampleing, and the original claim for linkage was eventually
withdrawn after analysis of a larger sample (Detera- of 200 healthy controls. The identified locus (z1.5 Mb
in size) is located in the proximal part of a region atWadleigh et al., 1989).
Additional chromosomal abnormalities in schizophre- chromosome 22q implicated independently inschizophre-
nia susceptibility through linkage studies (see above).nic patients described more recently include several
translocations, i.e., t(1;7) (p22;q22) (Gordon et al., 1994), This locus overlaps with the critical region involved in
the etiology of velo-cardio-facial (VCFS)/DiGeorge (DGS)t(2;18) (p11.2;p11.2) (Maziade et al., 1993), and t(6;11)
(q14.2;q25) (Holland and Gosden, 1990); inversions on syndromes (Driscoll et al., 1993), developmental disor-
ders caused at least in part by abnormalities of the neural4p15.2-q21.3 (Palmouret al.,1994); pericentric inversion
of 9p11-9q13 (Nanko et al., 1993b); trisomies of chromo- crest and neuronal cell migration. VCFS/DGS patients
typically present with some combination of congenitalsomes 5p14.1 (Malaspina et al., 1992), 5 (Rios et al.,
1995), and 8 (Ong and Robertson, 1995); fragile sites at heart disease, cleft palate, velopharyngeal incompe-
tence, facial dysmorphia, and learning disabilities. This8q24 and 10q24 (Garofalo et al., 1993); and interstitial
deletions at 9q32-q34.1 (Park et al., 1991), 22q11.1 (Kar- overlap provided the opportunity to test whether the
second criterion is satisfied, and it was actually shownayiorgou et al., 1995), and 5q21-23.1 (Bennett et al.,
1997). In addition, an apparent excess of sex chromo- that 4 out of 14 (29%) VCFS children with 22q11 dele-
tions develop schizophrenia or schizoaffective disordersomal aneuploides have been described in patients with
schizophrenia (reviewed by Delisi et al., 1994). in adolescence and adulthood (Pulver et al., 1994b).
Recent studies have started providing additional infor-It should be emphasized that most of the described
chromosomal anomalies are reports of isolated cases mation regarding this locus (Karayiorgou et al., 1996,
1997b; Papolos et al., 1996), and one study implicateddetected in karyotypic preparations. Because of thehigh
prevalence of thedisease, co-occurrence of schizophre- the 22q11 region in early-onset schizophrenia (Jacob-
sen et al., 1996). Interestingly, in this case there was nonia and a chromosomal abnormality does not necessar-
ily imply causative relationship, and this is probably the evidence of typical facial or cardiac features of VCFS,
supporting the view that psychosis should be bettercase for themajority of the abnormalities outlined above.
Therefore, given the amount of effort involved in going described as a result of the variable expressivity of the
22q11 deletions (rather than as a feature of the VCFSfrom the karyotypic anomaly to the isolation of the rele-
vant gene(s), a number of criteria need to be satisfied syndrome).
The work on 22q11 suggests that a higher yield ofto guarantee with reasonable certainty a causative rela-
tionship. Ideally, observations of a chromosomal abnor- cryptic abnormalities could be expected, should appro-
priately designed cytogenetic techniques (Flint et al.,mality and schizophrenia cosegregating in families would
greatly increase the likelihood of a true association. In 1995) be applied to psychiatric disorders. Recent work
(Beatty et al., 1996) provided further evidence in supportaddition, an independent positive linkage finding at the
same chromosomal region may strengthen the power of this prediction: examination of a random sample of
120 schizophrenic patients, using a structured physicalof any finding. However, even with true associations,
such invariable correlations may not exist in instances dysmorphic examination to screen for the presence of
26 facial and other physical features of VCFS, revealedof reduced penetrance or variable expressivity of the
chromosomal lesion, and supportive linkage might not that 13.3% subjects had facial and other VCFS-like
dysmorphic features. Learning disabilities or mental re-be observed in cases of weak-effect genes. To add to
thecomplexity, in families segregating the chromosomal tardation were also prevalent. This study extends previ-
ous studies that have reported an increased prevalenceabnormality, and where a true causal association exists
between the chromosomal abnormality and schizophre- of certain minor physical abnormalities in schizophrenic
patients (Gualtieri et al., 1982; Guy et al., 1983; Greennia, one might observe schizophrenia without the cyto-
genetic abnormality. This could be due to within-family et al., 1989; Lane et al., 1993) and suggests that other
microdeletions (among other potential etiologies) maygenetic heterogeneity of the disease, which can result
from bilineal transmission of genes, especially in families be causing the dysmorphic features identified (Bennett
et al., 1997).with multiply affected members (within-family heteroge-
neity has been demonstrated for other complex disor-
ders [Angrist et al., 1996; Salomon et al., 1996]). Thus, Analysis of Syndromes with Simple Inheritance
and Phenotypic Overlap with Schizophreniacriteria based on associations within one or few families
can be inconclusive, and themost reliablecriteria should Another approach to identify or narrow down a genomic
region involved in schizophrenia susceptibility is to iden-involve, when possible, demonstration of at least one
(or preferably both) of the following: (1) increased fre- tify diseases or syndromes with a simple Mendelian
mode of inheritance that share some phenotypic overlapquency of a specific chromosomal abnormality in a pop-
ulation of patients with schizophrenia, and (2) increased with schizophrenia. This could be due to a cytogenetic
abnormality affecting both genetic loci or due to coseg-frequency of schizophrenia in a population of patients
with a specific chromosomal abnormality. regation of two neighboring disease loci.
As noted above, schizophrenia and other psychiatricRecently, a chromosomal abnormality that seems to
satisfy both of these criteria has been described. Karayi- disorders have been reported in adults with velo-cardio-
facial syndrome (VCFS). There have also been severalorgou et al. (1995) reported and characterized two hemi-
zygous cryptic deletions at 22q11 in a sample of 100 reports of Marfan syndrome cosegregating with schizo-
phrenia (Romano and Linares, 1987; Melissari et al.,unrelated schizophrenic patients. The frequency of this
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1995), notably in five Ashkenazi Jewish families (Sirota were observed for any of these genes (Sasaki et al.,
1996). Other case/control studies used the ªrepeatet al., 1990) and more recently in a Sardinian family
(Mercuro et al., 1997). Marfan syndrome (MS) is a rela- expansion detectionº method (RED) to screen individual
genomes for the size of such expansions (RED analysistively rare autosomal dominant disorder of connective
tissue that is caused mainly by mutations in the fibrillin cannot discriminate among one or several different dy-
namic mutations). One study (Morris et al., 1995) re-1 gene at 15q21.1 (Dietz et al., 1991). Genetic linkage
analysis, using genetic markers spanning the MS locus, ported a significant difference in the distribution of CAG
repeat sizes found between affected and normal femalesfailed to find evidence of linkage with schizophrenia
across the Marfan syndrome locus (Kalsi et al., 1994; but not males and a marginally significant association
of the larger (69±136 repeat) expansions with a youngerKarayiorgou et al., 1994), but this is not surprising if a
weak-effect allele affecting only a subset of families lies age at onset. O'Donovan et al. (1995), using the same
methodology, demonstrated a significant shift towardin that locus. Further studies (e.g., search for chromo-
somal abnormalities, association studies with resident larger repeats in schizophrenic probands compared
with controls. In sharp contrast to Mendelian disordersgenes) are necessary to delineate this potentially inter-
esting association. caused by dynamic mutations, in bothstudies, thedistri-
bution of the expanded repeat size showed significant
overlap between the patient and control groups. In addi-
Search for Genetic Anticipation tion, the findings are not specific to schizophrenia, since
and Dynamic Mutations a similar effect has been described in patients with bipo-
It has longbeen observed that for certain inherited disor- lar disorder (Lindblad et al., 1995). However, the most
ders, there is a progressively earlier age of onset in problematic finding is that there does not appears to
successive generations, accompanied in many cases be a consistent relationship between repeat size and
by increasing severity. Whether this phenomenon (called age at onset of either schizophrenia or bipolar disorder,
anticipation) is real or the result of ascertainment bias suggesting that, contrary to expectation, dynamic muta-
has been an issue of controversy. For example, Penrose tions are unlikely to account for the majority of the popu-
(1948) put forward a series of arguments why anticipa- lation variability in the age of onset of these disorders.
tion in myotonic dystrophy might be artifactual. Ironi- Although both of these studies need to be replicated
cally, primarily due to the isolation of the myotonic dys- by other research teams, they represent a potentially
trophy gene by positional cloning approaches (Brook et promising line of research, provided that the remaining
al., 1992), it is now known that the mutation involved in very important challenge (which is identification and
myotonic dystrophy involves an expanded stretch of cloning of such expanded repeats) is dealtwith success-
CTG triplet repeats at the 39 end of the gene, and in- fully (Sanpei et al., 1996).
crease in the size of this unstable mutation over genera-
tions is associated with earlier age of onset and in-
creased severity of the disorder. Currently, the clinical Efforts to Reduce the Phenotypic Complexity
Genetic studies have been hindered not only by thephenomenon of genetic anticipation points to the in-
volvement of trinucleotide repeat expansions (so called high genetic heterogeneity of the disease and the low
penetrance of the disease alleles but also by the diffi-dynamic mutations) and several additional disorders, all
of which affect the nervous system (such as fragile X culty in defining schizophrenia phenotypes using con-
firmed and objective criteria (such as biological mark-syndrome, Huntington's chorea, and several ataxias),
have now been shown to involve trinucleotide repeat ers). The wide range of clinical features that constitute
schizophrenia could be due to the extensive geneticexpansions (Carpenter, 1994).
The evidence in favor of dynamic mutations in schizo- heterogeneity, but resolution of this issue awaits the
identification of susceptibility genes and the study ofphrenia is controversial, and if anything, genes carrying
such mutations appear to have only a weak effect. More their clinical correlates. Given our profound ignorance
on this subject, the most usual approach currently usedspecifically, components of anticipation, such as in-
creased severity, penetrance, and earlier age of onset to define schizophrenia for the genetic research de-
scribed above is to employ both a narrow (schizophreniain subsequent generations have been observed in some
schizophrenia families (although these studies should and schizoaffective disorder) and a broad (schizophre-
nia and schizoaffective disorder plus other spectrumbe interpreted cautiously, as it is extremely hard to rule
out ascertainment bias; Bassett and Honer, 1994; Asher- disorders) definition. There have been several attempts
to improve the definition of the phenotype for geneticson et al., 1994; Petronis et al., 1995). These observa-
tions, along with the evidence for dominant inheritance studies by using electrophysiological and neuropsycho-
logical measures (Holzman et al., 1988; Blackwood andand anticipation, the apparent prevalence of dominant
genes in schizophrenia, the irregular patterns of trans- Muir, 1990; Pogue-Geile et al., 1991). Inhibition of the
P50 response (a method developed for examining themission associated with triplet expansion, and the high
frequency of human brain genes containing trinucleotide filtering or gating of sensory input to higher brain cen-
ters) is diminished in schizophrenics (Judd et al., 1992)repeats justified screening for triplet repeat expansions
in schizophrenia. as well as in subjects with borderline or schizotypal
personality disorder and otherpsychiatric and neurolog-In several studies, specific genes with trinucleotide
repeat polymorphisms were investigated in case/control ical disorders. Recently, inhibition of the P50 response
was used as a phenotype for linkage analysis to identifystudies, but no unusually long alleles, which would sug-
gest abnormal expansion of the trinucleotide repeats, any chromosomal areas that contain genes responsible
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